Regulated cell death in myocardial ischemia-reperfusion injury

Area of Science:

• Cardiology
• Cell Biology
• Pathology

Background:

• Myocardial ischemia-reperfusion (I/R) injury is a critical complication in cardiovascular disease, often requiring reperfusion to save heart tissue.
• Cardiomyocyte death, historically attributed to apoptosis and necrosis, is central to I/R injury.
• Emerging research implicates novel regulated cell death (RCD) pathways in myocardial I/R.

Purpose of the Study:

• To review the roles of ferroptosis, necroptosis, and pyroptosis in myocardial I/R.
• To discuss the contribution of these RCD pathways to the pathology of I/R injury.
• To highlight the impact of RCD on cardiomyocyte loss and cardiac dysfunction.

Main Methods:

• Literature review of studies investigating ferroptosis, necroptosis, and pyroptosis in myocardial I/R.
• Analysis of mechanisms linking RCD to reactive oxygen species (ROS) generation, calcium stress, and inflammation.
• Examination of the downstream effects of RCD on cardiac remodeling and heart failure.

Main Results:

• Ferroptosis, necroptosis, and pyroptosis are identified as significant contributors to cardiomyocyte death in myocardial I/R.
• These RCD pathways modulate ROS production, calcium homeostasis, and inflammatory responses.
• Activation of these RCD pathways exacerbates adverse cardiac remodeling, leading to impaired cardiac function and heart failure.

Conclusions:

• Ferroptosis, necroptosis, and pyroptosis represent key mechanisms driving cardiomyocyte loss and pathology in myocardial I/R.
• Targeting these RCD pathways offers potential therapeutic strategies to mitigate I/R injury and prevent heart failure.
• Further research into the specific molecular triggers and modulators of these RCD pathways is warranted.